Novo CEO pressed by Senate to cut selling prices of obesity, diabetes drugs CEO Lars Fruergaard Jørgensen advised lawmakers the corporation would contemplate new talks with insurers with regard to the checklist price ranges of Wegovy and copyright when they pledge to help keep the medicines on their own formularies. https://kylermeuja.rimmablog.com/30104395/5-simple-techniques-for-healthcare-news